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Infections Tropicales, Faculté des Sciences Pharmaceutiques et Biologiques, Université Paris Descartes, Paris, FranceAbstractScabies is an ectoparasitic infestation caused by the mite Sarcoptes scabiei. Currently, S. scabiei is taxonomically divided into different varieties
on the basis of host origin. Genetics-based research on scabies has been conducted, but the data on genetic diversity of populations of this
mite in humans in Europe are lacking. We evaluated the genetic diversity of populations of S. scabiei. A large series of mites obtained from
humans in France and the data of mites from various hosts and geographical areas retrieved from GenBank were included to investigate
whether mites are divided into distinct populations. The study of cytochrome c oxidase subunit 1 gene polymorphisms were found to be
best suited for phylogenetic analysis. S. scabiei mites were distributed into three genetically distinct clades, with most mites clustering in
clades B and C. The Fst value and the Nm value calculated for mites included in clades B and C indicated a strong population structure
and a very low gene ﬂow between mites of those clades. The results of the present study not only support the rejection of the
hypothesis of panmixia for S. scabiei in humans but also suggest that mites belonging to different clades are genetically isolated. Moreover,
the results suggest that the subdivision of S. scabies in varieties according to animal or human hosts is not warranted. In conclusion,
S. scabiei mites in humans do not constitute a homogeneous population. Further investigations are now required to assess whether
different clinical forms of scabies are associated with particular haplotypes or clades.
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contagious infestation caused by the mite Sarcoptes scabiei
[1–5]. This neglected and emerging/reemerging disease is a
signiﬁcant public health problem worldwide and is the most
common skin disease in developing countries [6,7]. TheClin Microbiol Infect 2015; 21: 1107–1114
linical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved
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>100 million cases in 2010 [8]. Sarcoptic mange is also an
important veterinary disease, leading to signiﬁcant morbidity
and mortality in wild and domestic animals. It affects 104 spe-
cies of mammalian hosts worldwide, including companion,
livestock and wild animals, and it is an emerging problem in
many countries [5,6,9]. The most commonly described clinical
manifestations, among several possible different forms, are or-
dinary scabies (or classical scabies), nodular forms and crusted
scabies, the latter being extremely contagious. Crusted scabies
is usually associated with host factors such as older age and
immunosuppressed conditions, but it is not known whether
parasite factors may intervene [1].
The mite completes its entire life cycle on its host. Only
female mites burrow into the skin. The generation time lasts
about 3 weeks [3]. Most patients harbour a limited number of
mites, usually 5 to 15 females on the whole body. In case of
crusted scabies, the number can reach hundreds, thousands or
even millions. Crusted scabies cases evolve during many
months or years. Superinfection of ordinary or crusted scabies
cases may in theory lead to infections with genetically distinct
parasites, though this eventuality is probably rare [4].
For many years, host-associated populations of S. scabiei have
been taxonomically divided into morphologically indistinguish-
able varieties [5,10,11]. The monospeciﬁcity of these host-
speciﬁc varieties is still controversial, and current studies are
investigating whether they belong to different species. Previous
studies suggested that Sarcoptes is not a single panmictic pop-
ulation and that genetic subdivisions may occur according to the
host and/or geographical location [12,13]. The historical pro-
posed hypothesis of the “high degree of host speciﬁcity and low
degree of cross-infectivity of S. scabiei” [10] has been challenged
by some studies. Cross-infectivity was observed experimentally
on some occasions [6,14]. Natural apparent cross-infectivity
has been previously demonstrated during emerging epizootics
in sympatric wild animal host populations [15–17]. Trans-
mission of scabies mites between other species and humans can
occur, but it usually results in a short and self-limiting infection
[18–22].
Relatively little genetics-based research on S. scabiei has been
conducted. This is primarily because of difﬁculties in obtaining
suitable skin samples from hosts and in extracting adequate
amounts of genetic material from individual mites [23]. In
particular, data about the genetic diversity of S. scabiei in
humans in Europe are lacking.
In this study, we evaluated the genetic diversity of pop-
ulations of S. scabiei, including a large series of mites obtained in
humans in France and the data of mites from various hosts and
geographical areas retrieved from GenBank to investigate
whether mites are divided into distinct populations.Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectMethodsEthical clearance
This study was reviewed and approved by the Comité de
Protection des Personnes (institutional review board) of the
ethics committee CPP-Ile-de-France X (approval 2012/10/23),
and informed consent was obtained from all patients.
Collection of S. scabiei mites
Mites were prospectively collected in patients consulting at
Avicenne Hospital, Bobigny, and at Henri Mondor Hospital,
Créteil, two cities located in the suburbs of Paris, between
January 2013 and March 2014. Mites from dog and pig were
kindly provided by the parasitology department of the Veteri-
nary College of Alfort, Maisons-Alfort, France. All samples used
in this study were independent; only one patient was included in
the analysis when there were multiple cases within a family or
at the scale of a larger localized epidemic.
DNA extraction and gene ampliﬁcation
In total, genomic DNA from 62 mites (60 humans, one pig and
one dog) was individually extracted with the NucleoSpin Tissue
kit (NucleoSpin, Macherey-Nagel, Germany) [24,25]. A part of
the cox1 gene was ampliﬁed. PCR was carried out in 50 μL, and
reaction mixture contained 1× PCR buffer, 2.5 mM MgCl2,
1 mM of dNTPs, 1.25 U DNA polymerase AmpliTaq Gold
(Applied Biosystems, Courtaboeuf, France) and 0.25 μM of
primer (NavF: 50-TGATTTTTTGGTCACCCAGAAG-30;
NavR: 50-TACAGCTCCTATAGATAAAAC-30) [26]. Ampliﬁ-
cations conditions were as follows: an initial denaturation step
at 94°C for 5 minutes, followed by 35 cycles of denaturing at
94°C for 30 seconds, annealing at 51°C for 30 seconds, and
extending at 72°C for 40 seconds and 5 minutes of ﬁnal
extension at 72°C.
Sequence and phylogenetic analyses
The PCR-ampliﬁed products of 400 bp were puriﬁed and
directly sequenced. The Otodectes cynotis cox1 sequence
(KF891933) was retrieved from GenBank and used as the
outgroup to perform phylogenetic analysis. Multiple sequence
alignments of nucleotide sequences in this study and sequences
available from GenBank (n = 62) were generated using MAFFT
6.951. The data set was analysed with maximum likelihood (ML)
and Bayesian inference (BI). ML were performed using MEGA5
and RAxML-HPC 7.0.4 in CIPRES portal under a General Time-
Reversible (GTR + G) model. Support of internal branches was
evaluated by nonparametric bootstrapping with 500 replicates.
BI analysis was performed with MrBayes 3.2.1, conducting two
simultaneous runs with four parallel Markov chains (one coldious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 1107–1114
TABLE 1. Sarcoptes scabiei cox1 haplotypes from isolates collected in suburb of Paris, France (n [ 62), and sequences available in
GenBank (n [ 62)
N° of haplotype 3 5 6 7 8 9 14 16 17 32 41 50 53 59 60 71 80 86 95 96 104 116 131 134 137 140 143 147 155 185 191 197 198 200 224 227 236 239 254
H1 G G A T A A T A T A A A T T T T G T T T T T T T A A T G A C C A G A T A A A C
H2 A C G
H3 A C C G
H4 A T G
H5 A G
H6 A C T G
H7 T G
H8 T G
H9 G G T G
H10 T G
H11 T T G
H12 T G T
H13 A T T G
H14 T G
H15 A T G A
H16 C G
H17 G
H18 A T G
H19 G A C C T G
H20 G
H21 G
H22 A T G
H23 T G
H24
H25 A G
H26 G
H27 T G
H28 T T G
H29 G T A A C T T T G G A T
H30 G T A A C T T T G G A T
H31 A G T A C A C T T T G G A G T
H32 C T C C T T T G T
H33 C T C C T T T G G T
H34 A G A T C T C C T T T G G T
H35 C T C C T G T T G T
H36 C T C C T T T G T
H37 T C T C T C T T G T
H38 T C T C C C T G T T G T
H39 C T C C C T T T G T
nucleotide position
CLADE C
CLADE A
CLADE B
N° of haplotype 256 257 263 269 275 277 278 283 284 287 288 293 296 299 301 302 308 311 314 326 329 336 344 347 353 362 364 367 374 377 387 389 390 395 n= 
H1 C C G A T G C T G T C T A G G A T G T T C T T A C C A T T C G T T T 15
H2 1
H3 1
H4 T G C 1
H5 1
H6 T T 1
H7 T C T T 1
H8 T A 3
H9 T C 2
H10 T C 2
H11 T C 1
H12 T A 1
H13 T 5
H14 T C 11
H15 T A C C 1
H16 T C C 1
H17 T C C 5
H18 T C 1
H19 T A 1
H20 30
H21 2
H22 T 10
H23 T 2
H24 C 1
H25 T C 1
H26 1
H27 1
H28 T 1
H29 T A T C A T A C A T G T T A C 1
H30 T A T A T A C A T G T T A C 1
H31 T A T A T A G C A T G T T A A 1
H32 T A G T A C T A A T T A 4
H33 T A G T A C T A A T T A 2
H34 T A G T A C T A A T T 1
H35 T A G T A C T A A T T 2
H36 T A G T A C T A A T T 2
H37 A T A C T A A C T T 1
H38 T A T A T A A T T 1
H39 T A G T A T A A T T 4
nucleotide position
CLADE C
CLADE A
CLADE B
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CMI Andriantsoanirina et al. S. scabiei mite distribution 1111and three heated) for one million generations, sampling every
1000 generations and discarding the ﬁrst 25% of samples as
burn-in. The potential scale reduction factor approached 1.0,
and average of split frequencies under 0.01 were used for
examining convergence. All trees were visualized using FigTree
(http://tree.bio.ed.ac.uk/software/ﬁgtree). The number of poly-
morphic and parsimony-informative sites, haplotype and
nucleotide diversity were computed with DnaSP5 and Arlequin
3.5. To visualize the relationship between haplotypes, a median
joining haplotype network of cox1 sequence was constructed
using Network 4.6 according to geographical origin and host.ResultsThe sequence of the mitochondrial cytochrome c oxidase subunit
1 gene, cox1, was obtained in mites from 60 humans (age range,
1–77 years), one pig and one dog. Other sequences corre-
sponding to 62 mites from various hosts and geographical areas
were retrieved from GenBank (Supplementary Table S1). The
multiple alignments of a part of cox1 gene including 396 bp
revealed 73 polymorphic sites (18.4%), including 27 singleton
variable sites (two variants) and 46 parsimony-informative sites
(45 two variants and one three variant) (Table 1). All of the
successfully sequenced samples were assigned to only one
haplotype. In all, 39 haplotypes were observed among mites
collected from 13 different hosts, including humans, and eight
geographical areas. Twenty haplotypes were observed among
mites collected in humans: of these, (a) 10 were sequenced in
the present study and deposited in GenBank (accession nos.
KR058184–KR058193), haplotypes H20, H26, H27, H34–H39
and H21, with the latter being shared with mites collected from
animals; (b) 10 were previously described, H1, H24, H25,
H29–H33, H22 and H23; the two latter are shared with mites
collected from animals [12,27]. Nineteen haplotypes, H2–H19
and H28, were observed among mites collected from animals
only.
The phylogenetic trees based on ML and BI analyses showed
similar topologies with few differences in node support values.
Clades A (n = 3) and B (n = 17) harboured only mites collected
from humans (Fig. 1). Clade C included mites from animals
(n = 52) and humans (n = 52). Mites from animals were
collected from 12 animal species: rabbit (Oryctolagus cuniculus)FIG. 1. Phylogenetic relationship among Sarcoptes scabiei from humans and a
Otodectes cynotis (KF891933). Maximum likelihood (ML) and Bayesian inferenc
and posterior probabilities of BI analysis (right of slash) are indicated at node
and 0.5 are shown. PIG1, DOG1 and samples including “M” or “S” and one
numbers of other sequences are provided in Supplementary Table S1.
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology an(n = 13), dog (Canis familiaris) (n = 12), water buffalo (Bubalus
bubalis) (n = 8), raccoon dog (Nyctereutes procyonoides) (n = 6),
sheep (Ovis aries) (n = 5), pig (Sus scrofa domesticus) (n = 2),
chimpanzee (Pan troglodytes) (n = 1), cattle (Bos taurus) (n = 1),
wombat (Wombatus ursinus) (n = 1), wallaby (Macropus agilis)
(n = 1), Japanese serow (Capricornis crispus) (n = 1) and Japanese
marten (Martes melampus) (n = 1). Both phylogenetic and
network analyses showed that S. scabiei mites were distributed
into three genetically distinct clades and that each clade formed
a well-supported monophyletic group (Fig. 2).
Mites belonging to clade A were obtained in Panama (Fig. 2).
The geographic distribution of clade B was restricted to
Australia and France. Mites belonging to clade C were more
largely distributed on ﬁve continents. Mites of clades B and C
were sympatric in France and in Australia.
Estimates of genetic diversity for the 124 sequences and
within clade B and clade C were high (Table 2). The Fst value, a
measure of genetic population differentiation, calculated for
clade B and clade C was 0.844, indicating very strong population
structure. The population gene ﬂow value, Nm, was 0.09,
reﬂecting very low gene ﬂow estimates between mites of clades
B and C. Considering mites collected only from humans in
clades B (n = 17) and C (n = 52), the Fst value was 0.890,
indicating very strong population structure, and the Nm value
was 0.06, reﬂecting very low gene ﬂow estimates between
mites of those subpopulations. Within clade C, for mites ob-
tained from animals (n = 52) and mites obtained from humans
(n = 52), the Fst value was 0.435, indicating strong population
structure; the Nm value was 0.65, reﬂecting relatively low gene
ﬂow. Considering mites collected from animals (n = 52) and all
mites collected from humans (n = 72), the Fst value was 0.228
and the Nm value was 1.69. For mites collected in Australia
(n = 14) and in France (n = 62) the Fst was 0.165 and the Nm
value was 2.52, reﬂecting substantial gene ﬂow.DiscussionThe most striking observation of the present study was that
S. scabiei mites in humans were mainly distributed into three
genetically distinct clades. Our results are consistent with two
previous analyses using cox1 as a genetic marker but not
including human samples of European origin [12,28]. We didnimals based on the cox1 nucleotide sequences. Tree was rooted with
e (BI) gave similar topology. Bootstrap percentages of ML (left of slash)
s. All nodes supported with bootstrap and posterior probabilities >50%
or two numbers in their names were collected in France. Accession
d Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 1107–1114
FIG. 2. Haplotype map for part of cox1 gene of Sarcoptes scabiei collected from humans and animals in different geographical locations. Size of circles is
proportional to haplotype frequency. (a) Haplotype network according to geographical origin and (b) host, inferred under median joining as imple-
mented in Network 4.6 software.
1112 Clinical Microbiology and Infection, Volume 21 Number 12, December 2015 CMInot include the samples collected in Chinese humans (n = 5) of
the study by Zhao et al. [28] in our analysis because the size of
the cox1 fragment they used, 317 bp, was shorter than in our
study.
Clades A and B clustered only mites collected from humans.
More samples collected from various hosts and geographical
areas are required to assess whether clades A or/and B may
include mites from animals. Clade A was represented only by
three samples collected in Panama with no information relative
to the human host. Two other mites collected in the New
World, from dogs in the United States, clustered in clade C.
The Fst value and the Nm value calculated for all mites
included in clades B and C indicated a strong population
structure and a low gene ﬂow between mites of those clades,TABLE 2. Estimates of genetic diversity of Sarcoptes scabiei mites
Characteristic No. of sequences No. of haploty
All mites 124 39
Mites clade B 17 8
Mites clade C 104 28
Mites collected in humans, clade C 52 9
Mites collected in humans, all clades 72 20
Mites collected in animals, clade C 52 22
Mites collected in Australia 14 9
Mites collected in France 62 13
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectreﬂecting a clear genetic population differentiation. These data
not only support the rejection of the hypothesis of panmixia for
S. scabiei in humans but also suggest that mites belonging to
different clades are genetically isolated even if they were
collected in the same area.
The genetic differentiation, within clade C, between mites
from humans and mites from animals appeared substantial, but
some gene ﬂow, albeit limited, does occur between these mites.
Another ﬁnding of the study was that mites from dogs appeared
to be not genetically different from mites from humans on the
basis of cox1 genotyping. This result is consistent with a pre-
vious study using a part of 12S rRNA for genotyping and
including a smaller number of isolates [29]. Additional analyses
of our samples with 12S rRNA and 16S rRNA genotypingpes Haplotype diversity (SD) Nucleotide diversity (π) (SD)
0.91 (0.016) 0.021 (0.0025)
0.89 (0.046) 0.0103 (0.0028)
0.87 (0.02) 0.007 (0.00045)
0.59 (0.057) 0.0021 (0.0004)
0.78 (0.041) 0.0267 (0.0034)
0.91 (0.023) 0.0082 (0.0007)
0.9 1 (0.059) 0.035 (0.0031)
0.717 (0.050) 0.0183 (0.0035)
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 1107–1114
CMI Andriantsoanirina et al. S. scabiei mite distribution 1113showed convergent subclustering of mites in clades B and C
(data not shown). We could not incorporate in these analyses
12S rRNA and 16S rRNA sequences from mites of other
studies because such data are lacking in GenBank.
In northern Australia, Walton et al. [30], using microsatellites
markers, claimed that gene ﬂow between scabies mite pop-
ulations on humans and dogs was extremely rare. However,
their study included only seven human noncrusted cases. When
the same team studied the relationship of S. scabiei mites
collected from dogs and humans by using cox1, they found that
mites from dogs and humans clustered in the same group. Using
the microsatellite approach on the same samples, the three
mites from humans were then assigned to another group
including only mites collected in humans. Considering the low
number of cases and the inconsistency of results between ap-
proaches, the conclusions drawn from those studies appear
questionable. In a recent study, Zhao et al. [28], using cox1 for
phylogenetic analysis, reported that mites from dogs in China,
Australia and the United States clustered with mites collected
from Australian people. Those authors concluded that humans
could be infected with mites from dogs. Our results on this
point are in agreement with those authors.
Currently, S. scabiei is taxonomically divided into different
varieties based on host origin [10]. According to our results and
other recent studies [12,28], such varieties are no longer
warranted. A generally accepted hypothesis suggests that
humans and protohumans were the initial source of animal
scabies; dogs and other domestic animals were then infested
and were themselves a source for other species of wildlife [5].
One can imagine that infection of animals from humans or
protohumans resulted from the adaptation to animal hosts of
mites from clade C and not from clade B (provided that no
animal host will be found in the future for mites of clade B).
Given the gene ﬂow observed between mites collected on
humans and animals, scabies may be considered as a zoonosis,
even if scabies acquired from animals is usually clinically mod-
erate and transient in humans [5]. Our results and that of other
recent studies suggest that we ought to reevaluate the level of
transmission between humans and animals and between do-
mestic and wild animals [16,31].
Clade B harboured mites collected only in Australia and
France. More samples from various geographical areas are
required to assess whether clade B may include mites of other
geographical origin. Clade C harboured also, but not exclusively,
mites from Australia and France. Those data are consistent with
the hypothesis that Australian mite populations result from a
European introduction of S. scabiei by immigrating individuals
and/or their companion animals, as suggested by previous studies
[29,32]. Moreover, our data strongly suggest a double event for
the introduction of the two clades, B and C, in Australia.Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology anIn conclusion, S. scabiei mites in humans do not constitute a
homogeneous population. By using the methodology imple-
mented here, each isolate may be genotyped and assigned into
one of the distinct clades. Sarcoptes population genetic sub-
structuring may have major consequences in terms of patho-
physiology and epidemiology. Further investigations are now
required to assess whether different clinical forms of scabies
are associated with particular haplotypes or clades. Sarcoptes
population genetic substructuring ought to be considered in the
emergence and spread of acaricide resistance, in Sarcoptes
vaccine development and in diagnostic test development and
implementation.Transparency declarationThis study was supported by the French Society of Derma-
tology, Research Grant March 2013. The funders had no role in
study design, data collection and analysis, decision to publish or
preparation of the manuscript. All authors report no conﬂicts
of interest relevant to this article.Appendix A. Supplementary dataSupplementary data related to this article can be found at http://
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